Authors:
BOUIX M
GOUZI J
CHARLEUX B
VAIRON JP
GUINOT P
Citation: M. Bouix et al., SYNTHESIS OF AMPHIPHILIC POLYELECTROLYTE BLOCK-COPOLYMERS USING LIVING RADICAL POLYMERIZATION - APPLICATION AS STABILIZERS IN EMULSION POLYMERIZATION, Macromolecular rapid communications, 19(4), 1998, pp. 209-213
Citation: P. Guinot, ANTISENSE OLIGONUCLEOTIDES AS THERAPY FOR VIRAL-INFECTIONS, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 32-32
Citation: J. Temsamani et P. Guinot, ANTISENSE OLIGONUCLEOTIDES - A NEW THERAPEUTIC APPROACH, Biotechnology and applied biochemistry, 26, 1997, pp. 65-71
Citation: P. Guinot et al., RANDOM AND BLOCK 2-ALKYL-2-OXAZOLINES TELECHELIC MACROMONOMERS, Macromolecular chemistry and physics, 197(1), 1996, pp. 1-17
Authors:
MARANINCHI D
BARBET J
BATTAIS J
EMILIE D
GOEHRS JM
GUINOT P
MANNONI P
MEYER P
ROMETLEMONNE JL
TROUVIN JH
CALVO F
GALANAUD P
GOUYETTE A
JULOU CL
MARCEL T
MOREL A
QUENTINMILLET MJ
SCHATZ C
WIJDENES J
Citation: D. Maraninchi et al., WHICH STATUS FOR DRUGS OF BIOLOGICAL ORIG IN, Therapie, 51(4), 1996, pp. 431-433
Citation: J. Auzerie et al., GROWTH-HORMONE RELEASING HORMONE-TREATMEN T IN GROWTH-HORMONE DEFICIENCY - ACTUAL DATA AND FUTURE-PROSPECTS, Archives de pediatrie, 2(4), 1995, pp. 365-372
Authors:
HILLIQUIN P
GUINOT P
CHERMATIZARD V
PUECHAL X
MENKES CJ
Citation: P. Hilliquin et al., TREATMENT OF RHEUMATOID-ARTHRITIS WITH PLATELET-ACTIVATING-FACTOR ANTAGONIST BN-50730, Journal of rheumatology, 22(9), 1995, pp. 1651-1654
Authors:
BROCHET B
GUINOT P
ORGOGOZO JM
CONFAVREUX C
RUMBACH L
LAVERGNE V
BOULLIAT J
CAUSSANEL JP
CESARO P
CHEDRU F
COLLARD M
DEGOS CF
DESTEE A
GOAS JY
GONSETTE R
FEVE JR
ROULLET E
SETIEY A
VIALLET F
WARTER JM
Citation: B. Brochet et al., DOUBLE-BLIND PLACEBO-CONTROLLED MULTICENTER STUDY OF GINKGOLIDE-B IN TREATMENT OF ACUTE EXACERBATIONS OF MULTIPLE-SCLEROSIS, Journal of Neurology, Neurosurgery and Psychiatry, 58(3), 1995, pp. 360-362
Authors:
HILLIQUIN P
NATOUR J
AISSA J
GUINOT P
LAOUSSADI S
BENVENISTE J
MENKES CJ
ARNOUX B
Citation: P. Hilliquin et al., TREATMENT OF CARRAGEENAN-INDUCED ARTHRITIS BY THE PLATELET-ACTIVATING-FACTOR ANTAGONIST BN-50730, Annals of the Rheumatic Diseases, 54(2), 1995, pp. 140-143
Authors:
PIGNOL B
MAISONNET T
GUINOT P
MENCIAHUERTA JM
BRAQUET P
Citation: B. Pignol et al., EFFECT OF PLATELET-ACTIVATING-FACTOR ON IN-VITRO AND IN-VIVO INTERLEUKIN-6 PRODUCTION, Mediators of inflammation, 3(4), 1994, pp. 281-285
Citation: P. Guinot et P. Braquet, EFFECTS OF THE PAF ANTAGONISTS, GINKGOLIDES (BN-52063, BN-52021), IN VARIOUS CLINICAL INDICATIONS, Journal of lipid mediators and cell signalling, 10(1-2), 1994, pp. 141-146
Citation: P. Guinot, CLINICAL-EXPERIENCE WITH PLATELET-ACTIVATING-FACTOR ANTAGONISTS - PAST, PRESENT, AND NEAR FUTURE, Clinical reviews in allergy, 12(4), 1994, pp. 397-417
Citation: J. Duchier et al., EFFECT OF BN-50730, A SPECIFIC PAF ANTAGONIST, ON PAF-INDUCED PLATELET-AGGREGATION AND SKIN-RESPONSES IN HEALTHY-HUMAN VOLUNTEERS, Drug investigation, 8(2), 1994, pp. 95-103
Authors:
DHAINAUT JFA
TENAILLON A
LETULZO Y
SCHLEMMER B
SOLET JP
WOLFF M
HOLZAPFEL L
ZENI F
DREYFUSS D
MIRA JP
DEVATHAIRE F
GUINOT P
Citation: Jfa. Dhainaut et al., PLATELET-ACTIVATING-FACTOR RECEPTOR ANTAGONIST BN-52021 IN THE TREATMENT OF SEVERE SEPSIS - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED,MULTICENTER CLINICAL-TRIAL, Critical care medicine, 22(11), 1994, pp. 1720-1728
Authors:
LAGENTE V
BOICHOT E
CARRE C
GUINOT P
MENCIAHUERTA JM
BRAQUET P
Citation: V. Lagente et al., EFFECTS OF THE PLATELET-ACTIVATING-FACTOR ANTAGONISTS BN-52021 AND BN-50730 ON ANTIGEN-INDUCED BRONCHIAL HYPERRESPONSIVENESS AND EOSINOPHILINFILTRATION IN LUNG FROM SENSITIZED GUINEA-PIGS, Clinical and experimental allergy, 23(12), 1993, pp. 1002-1010
Authors:
DAHAN R
JAILLON P
LEHNER JP
CAZOR JL
CLOARECBLANCHARD L
DAHAN R
DUCHIER J
GUINOT P
JAILLON P
LEHNER JP
LOEB F
MACQUINMAVIER C
PUECH A
ROLAND E
ROUVEIX B
TEULEESPIE M
THULLIEZ C
VITOU P
Citation: R. Dahan et al., HOW TO PREDICT THE THERAPEUTIC DOSE RANGE TO BE TESTED IN PHASE-III CLINICAL-TRIALS, Therapie, 48(4), 1993, pp. 297-301
Authors:
HILLIQUIN P
GUINOT P
CHERMATIZARD V
ARNOUX B
MENKES CJ
Citation: P. Hilliquin et al., TREATMENT OF RHEUMATOID-ARTHRITIS (RA) BY A PAF-ACETHER ANTAGONIST (BN 50730) - RESULTS OF AN OPEN STUDY, Arthritis and rheumatism, 36(9), 1993, pp. 190000216-190000216
Authors:
TENAILLON A
DHAINAUT JF
LETULZO Y
SCHLEMMER B
SOLET JP
WOLFF M
HOLZAPFEL L
ZENI F
DREYFUSS D
MIRA JP
CHRETIEN JM
LAVERGNE V
GUINOT P
Citation: A. Tenaillon et al., EFFICACY OF PAF ANTAGONIST (BN-52021) IN REDUCING MORTALITY OF PATIENTS WITH SEVERE GRAM-NEGATIVE SEPSIS, The American review of respiratory disease, 147(4), 1993, pp. 97-97
Authors:
TENAILLON A
DHAINAUT JF
LETULZO Y
SCHLEMMER B
SOLET JP
WOLFF M
HOLZAPFEL L
ZENI F
DREYFUSS D
MIRA JP
CHRETIEN JM
LAVERGNE V
GUINOT P
Citation: A. Tenaillon et al., EFFICACY OF PAF ANTAGONIST (BN-52021) IN REDUCING MORTALITY OF PATIENTS WITH SEVERE GRAM-NEGATIVE SEPSIS, The American review of respiratory disease, 147(4), 1993, pp. 196-196